A new mRNA vaccine against lung cancer, known as BNT116, has shown encouraging results in its initial trials, offering hope for improved treatment options. The vaccine, developed using mRNA technology, aims to train the immune system to recognise and attack cancer cells, potentially leading to a significant reduction in cancer recurrence. Thanos Dimopoulos, a leading … Continue reading New mRNA vaccine touted as promising treatment against lung cancer